Company Description
CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system.
It offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon).
The company also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premise video access and download solution; CapsoAccess, a Capsule data access system; CapsoView, a data access reading device for viewing capsule videos; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services.
It serves gastrointestinal medical practices, clinics, and hospitals. The company sells its products to distributor customers who resell products.
The company was formerly known as Capso Vision Inc. and changed its name to CapsoVision, Inc. in May, 2016.
CapsoVision, Inc. was incorporated in 2005 and is headquartered in Saratoga, California.
| Country | United States |
| Founded | 2005 |
| IPO Date | Jul 2, 2025 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 90 |
| CEO | Kang Wang |
Contact Details
Address: 18805 Cox Avenue, Suite 250 Saratoga, California 95070 United States | |
| Phone | 408 624 1488 |
| Website | capsovision.com |
Stock Details
| Ticker Symbol | CV |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $5.00 |
| CIK Code | 0001378325 |
| CUSIP Number | 140935107 |
| Employer ID | 20-3369494 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Kang-Huai (Johnny) Wang | President, Chief Executive Officer and Director |
| Kevin Lundquist | Chief Financial Officer |
| Rebecca Petersen | Director of Clinical Affairs |
| Douglas Atkinson | Head of Global Sales |
| Chen Lung Tsai | Chair |
| Hui Ying (Patty) Kuo | Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 10, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
| Jul 3, 2025 | 8-K | Current Report |
| Jul 3, 2025 | 424B4 | Prospectus |
| Jul 2, 2025 | CERT | Certification by an exchange approving securities for listing |
| Jul 1, 2025 | EFFECT | Notice of Effectiveness |
| Jun 27, 2025 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Jun 13, 2025 | 8-A12B | Registration of securities |
| Jun 13, 2025 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Jun 2, 2025 | FWP | Free Writing Prospectus |
| May 30, 2025 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |